Logo Logo
Hilfe
Hilfe
Switch Language to English

Dimitriadis, Konstantinos; Schmidbauer, Moritz und Boesel, Julian (2022): Neurointensivmedizin und COVID-19. In: Nervenarzt, Bd. 94, Nr. 2: S. 84-92

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

This review article summarizes important findings on the interfaces between the coronavirus disease 2019 (COVID-19) pandemic and neurology with an emphasis of the implications for neurointensive care medicine. More specifically, the prevalence, pathomechanisms and impact of neurological manifestations are reported. The most common neurological manifestations of critically ill COVID-19 patients are cerebrovascular complications, encephalopathies and intensive care unit-acquired weakness (ICUAW). A relevant direct pathophysiological effect by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) itself has not yet been established with certainty. In fact, indirect systemic inflammatory processes triggered by the viral infection and side effects of intensive care treatment are much more likely to cause the reported sequelae. The impact of the pandemic on patients with neurological disorders and neurointensive care medicine is far-reaching but not yet sufficiently studied.

Dokument bearbeiten Dokument bearbeiten